Phosphatidylserine and Memory: The Brain Phospholipid with Clinical Evidence

Phosphatidylserine (PS) is a phospholipid — a fat molecule with a phosphate head group — that is a critical structural component of cell membranes throughout the body, but is particularly concentrated in the brain. It makes up approximately 15% of the brain's total phospholipid content and is especially abundant in the inner leaflet of neuronal membranes, where it plays essential roles in cell signalling, neurotransmitter release, and the activation of protein kinase C — an enzyme central to memory formation and synaptic plasticity. PS levels in the brain decline with age, and this decline has been associated with age-related cognitive impairment.

The FDA Qualified Health Claim. In 2003, the US Food and Drug Administration (FDA) issued a qualified health claim for phosphatidylserine, stating: 'Consumption of phosphatidylserine may reduce the risk of dementia in the elderly' and 'Consumption of phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly.' This is a qualified claim — meaning the evidence is suggestive but not conclusive — but it is notable as one of the very few dietary supplements to receive any FDA health claim related to cognitive function. The claim was based on a review of multiple clinical trials conducted primarily in the 1980s and 1990s using bovine-derived PS.

Clinical Evidence: Memory and Cognitive Function. The most rigorous trials of PS supplementation have found consistent, if modest, benefits for memory and cognitive function in older adults with age-related cognitive decline. A 1991 double-blind RCT by Crook et al. (Neurology) found that 300mg/day of PS for 12 weeks significantly improved memory performance in 149 patients with age-associated memory impairment — particularly for tasks involving learning names, faces, and telephone numbers. A 1992 multi-centre RCT by Engel et al. found similar improvements in 425 patients with early Alzheimer's disease. A 2010 RCT by Kato-Kataoka et al. (Journal of Clinical Biochemistry and Nutrition) found that 100mg/day of soy-derived PS for 6 months improved memory and cognitive function in 78 elderly Japanese adults with memory complaints.

Stress and Cortisol. Beyond memory, PS has a well-documented effect on the stress response. Multiple studies have found that PS supplementation blunts the cortisol and ACTH response to physical and psychological stress. A 1992 study by Monteleone et al. (Neuroendocrinology) found that 800mg/day of PS significantly reduced cortisol and ACTH responses to exercise stress. This cortisol-blunting effect has made PS popular among athletes for recovery and among people with chronic stress — though the doses used in stress studies (400–800mg/day) are higher than those used in cognitive studies (100–300mg/day).

Practical Guidance. The standard dose for cognitive support is 100–300mg/day of soy-derived PS (bovine-derived PS is no longer commercially available due to BSE concerns). PS is fat-soluble and should be taken with food. It is generally well tolerated; the most commonly reported side effects are mild gastrointestinal discomfort and insomnia at higher doses. PS is often combined with DHA (omega-3) in commercial formulations — this combination has theoretical synergy, as DHA is required for PS synthesis in the brain. Effects on memory typically require 4–12 weeks of consistent supplementation. PS is most likely to be beneficial in older adults with subjective memory complaints or mild cognitive impairment; evidence for benefit in younger, cognitively healthy adults is limited.